[1] “Marathon mit Multipler Sklerose: Jasmin Nunige ist Meisterin des Restarts | ISPO.com.” Accessed: Dec. 18, 2023. [Online]. Available: https://www.ispo.com/outdoor-society/menschen/marathon-mit-multipler-sklerose-weiter-immer-weiter
[2] “Wie gruppieren sich MS-Symptome? Erstsymptome und der Wandel der MS (Teil 2).” Accessed: Dec. 18, 2023. [Online]. Available: https://www.multiplesklerose.ch/de/aktuelles/detail/wie-gruppieren-sich-ms-symptome-erstsymptome-und-der-wandel-der-ms-teil-2
[3] C. Gasperi, A. Hapfelmeier, T. Daltrozzo, A. Schneider, E. Donnachie, and B. Hemmer, “Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis,” Neurology, vol. 96, no. 24, Jun. 2021, doi: 10.1212/WNL.0000000000012074 .
[4] “Cortisol,” Wikipedia. Oct. 27, 2023. Accessed: Dec. 20, 2023. [Online]. Available: https://de.wikipedia.org/w/index.php?title=Cortisol&oldid=238550036
[5] “Prednisolon,” Wikipedia. Oct. 03, 2023. Accessed: Dec. 18, 2023. [Online]. Available: https://de.wikipedia.org/w/index.php?title=Prednisolon&oldid=237841560
[6] “Methylprednisolon,” Wikipedia. Oct. 03, 2023. Accessed: Dec. 20, 2023. [Online]. Available: https://de.wikipedia.org/w/index.php?title=Methylprednisolon&oldid=237842128
[7] GKV-Spitzenverband, “Startseite.” Accessed: Dec. 18, 2023. [Online]. Available: https://www.gkv-spitzenverband.de/
[8] A. Waschbisch, A. Tallner, K. Pfeifer, and M. Mäurer, “Multiple Sklerose und Sport,” Nervenarzt, vol. 80, pp. 688–692, Jun. 2009, doi: 10.1007/s00115-008-2639-3 .
[9] Catching Kayla 6 mins, (Jan. 20, 2015). Accessed: Dec. 18, 2023. [Online Video]. Available: https://www.youtube.com/watch?v=7fhMA_rIb1k
[10] P. N. Taylor and J. S. Davies, “A review of the growing risk of vitamin D toxicity from inappropriate practice,” Br. J. Clin. Pharmacol., vol. 84, no. 6, pp. 1121–1127, Jun. 2018, doi: 10.1111/bcp.13573 .
[11] A. Asif and N. Farooq, “Vitamin D Toxicity,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Dec. 19, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK557876/
[12] “TecfideraTM | Therapien von Biogen | BiogenLinc.de.” Accessed: Dec. 18, 2023. [Online]. Available: https://biogenlinc.de/therapien/tecfidera/
[13] “Teriflunomid (Aubagio®).” Accessed: Dec. 18, 2023. [Online]. Available: https://www.dmsg.de/multiple-sklerose/ms-behandeln/medikamente-versteckt/teriflunomid-aubagior
[14] “Gebrauchsinformation: Copaxone 40 mg/ml Injektionslösung in einer Fertigspritze”. [Online]. Available: https://www.teva.de/assets/products/de/pkg_insert/Copaxone%2040%20mgml%20Injektionslosung%20in%20einer%20Fertigspritze%20-%207.pdf?pzn=11013299
[15] J. Borsch, “Rituximab-Biosimilar vor der Zulassung,” DAZ.online. Accessed: Dec. 19, 2023. [Online]. Available: https://www.deutsche-apotheker-zeitung.de/news/artikel/2016/12/19/rituximab-biosimilar-vor-der-zulassung
[16] “Glossar: Patentschutz.” Accessed: Dec. 19, 2023. [Online]. Available: https://www.progenerika.de/news/glossar/patentschutz/
[17] K. Selmaj, A. Członkowska, H. Kwieciński, J. Losy, R. Podemski, and Z. Stelmasiak, “[Open trial of the effectiveness of interferon beta 1a (Avonex) in multiple sclerosis. Clinical assessment using motor coordination tests],” Neurol. Neurochir. Pol., vol. 37, no. 6, pp. 1163–1183, 2003.
[18] “Pivotal Trials Information | AVONEX® (interferon beta-1a).” Accessed: Dec. 18, 2023. [Online]. Available: https://www.hcp.avonex.com/en_us/home/hcp-efficacy/hcp-pivotal-trials.html
[19] Genentech, Inc., “Phase II, Multicenter, Randomized, Parallel-Group, Partially Blinded, Placebo and Avonex Controlled Dose Finding Study to Evaluate the Efficacy As Measured by Brain MRI Lesions, and Safety of 2 Dose Regimens of Ocrelizumab in Patients With RRMS,” clinicaltrials.gov, Clinical trial registration NCT00676715, Oct. 2023. Accessed: Jan. 01, 2023. [Online]. Available: https://clinicaltrials.gov/study/NCT00676715
[20] “Search | Cochrane Library.” Accessed: Dec. 18, 2023. [Online]. Available: https://www.cochranelibrary.com/cdsr/reviews
[21] K. Göbel et al., “Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells,” Nat. Commun., vol. 7, no. 1, Art. no. 1, May 2016, doi: 10.1038/ncomms11626 .
[22] H. Malkki, “Coagulation factors could mediate neuroinflammation in multiple sclerosis,” Nat. Rev. Neurol., vol. 12, no. 12, Art. no. 12, Dec. 2016, doi: 10.1038/nrneurol.2016.175 .
[23] A. Sharma et al., “Comprehensive Profiling of Blood Coagulation and Fibrinolysis Marker Reveals Elevated Plasmin-Antiplasmin Complexes in Parkinson’s Disease,” Biology, vol. 10, no. 8, p. 716, Jul. 2021, doi: 10.3390/biology10080716 .
[24] M. Cortes-Canteli, D. Zamolodchikov, H. J. Ahn, S. Strickland, and E. H. Norris, “Fibrinogen and Altered Hemostasis in Alzheimer’s Disease,” J. Alzheimers Dis. JAD, vol. 32, no. 3, pp. 599–608, 2012, doi: 10.3233/JAD-2012-120820 .
[25] “Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex – M Matysiak, B Makosa, A Walczak, K Selmaj, 2008.” Accessed: Dec. 18, 2023. [Online]. Available: https://journals.sagepub.com/doi/abs/10.1177/1352458508090666
[26] S. Krieger, S. F. Sorrells, M. Nickerson, and T. W. W. Pace, “Mechanistic insights into corticosteroids in multiple sclerosis: War horse or chameleon?,” Clin. Neurol. Neurosurg., vol. 119, pp. 6–16, Apr. 2014, doi: 10.1016/j.clineuro.2013.12.021 .
[27] P. Suarez-Bregua, P. M. Guerreiro, and J. Rotllant, “Stress, Glucocorticoids and Bone: A Review From Mammals and Fish,” Front. Endocrinol., vol. 9, 2018, Accessed: Dec. 18, 2023. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fendo.2018.00526
[28] T. P. Braun and D. L. Marks, “The regulation of muscle mass by endogenous glucocorticoids,” Front. Physiol., vol. 6, p. 12, 2015, doi: 10.3389/fphys.2015.00012 .
[29] “Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis | Science.” Accessed: Dec. 18, 2023. [Online]. Available: https://www.science.org/doi/10.1126/science.abj8222
[30] S. S. Soldan and P. M. Lieberman, “Epstein–Barr virus and multiple sclerosis,” Nat. Rev. Microbiol., vol. 21, no. 1, Art. no. 1, Jan. 2023, doi: 10.1038/s41579-022-00770-5 .
[31] H.-R. Rossi, O. Uimari, A. Terho, P. Pesonen, S. Koivurova, and T. Piltonen, “Increased overall morbidity in women with endometriosis: a population-based follow-up study until age 50,” Fertil. Steril., vol. 119, no. 1, pp. 89–98, Jan. 2023, doi: 10.1016/j.fertnstert.2022.09.361 .
[32] A. Katiyar, S. Sharma, T. P. Singh, and P. Kaur, “Identification of Shared Molecular Signatures Indicate the Susceptibility of Endometriosis to Multiple Sclerosis,” Front. Genet., vol. 9, 2018, Accessed: Dec. 18, 2023. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fgene.2018.00042
[33] P. Chen, R. Mamillapalli, S. Habata, and H. S. Taylor, “Endometriosis Cell Proliferation Induced by Bone Marrow Mesenchymal Stem Cells,” Reprod. Sci. Thousand Oaks Calif, vol. 28, no. 2, pp. 426–434, Feb. 2021, doi: 10.1007/s43032-020-00294-4 .
[34] C. Hajat and E. Stein, “The global burden of multiple chronic conditions: A narrative review,” Prev. Med. Rep., vol. 12, pp. 284–293, Oct. 2018, doi: 10.1016/j.pmedr.2018.10.008 .
[35] “Malu Dreyer,” Wikipedia. Nov. 25, 2023. Accessed: Dec. 18, 2023. [Online]. Available: https://de.wikipedia.org/w/index.php?title=Malu_Dreyer&oldid=239448317
[36] A. Gernandt, “Howard Carpendale über sein Leben mit Multiple Sklerose,” Der Spiegel, Jan. 14, 2016. Accessed: Dec. 18, 2023. [Online]. Available: https://www.spiegel.de/geschichte/howard-carpendale-ich-habe-vor-besoffenen-gaesten-gesungen-a-1070885.html
[37] R. Wang et al., “The effect of magnesium supplementation on muscle fitness: a meta-analysis and systematic review,” Magnes. Res., vol. 30, no. 4, pp. 120–132, Nov. 2017, doi: 10.1684/mrh.2018.0430 .
[38] M. Guo et al., “Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota,” Nutrients, vol. 15, no. 23, p. 4915, Nov. 2023, doi: 10.3390/nu15234915 .
[39] J. Su, H. Braat, and M. P. Peppelenbosch, “Gut Microbiota-Derived Propionate Production May Explain Beneficial Effects of Intermittent Fasting in Experimental Colitis,” J. Crohns Colitis, vol. 15, no. 6, pp. 1081–1082, Jun. 2021, doi: 10.1093/ecco-jcc/jjaa248 .
[40] C. Scully, “26 – Complementary and alternative medicine,” in Scully’s Medical Problems in Dentistry (Seventh Edition), C. Scully, Ed., Oxford: Churchill Livingstone, 2014, pp. 652–658. doi: 10.1016/B978-0-7020-5401-3.00026-6 .
[41] S. Schwarz, “Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: a report of two cases,” J. Neurol. Neurosurg. Psychiatry, vol. 69, no. 4, pp. 516–518, Oct. 2000, doi: 10.1136/jnnp.69.4.516 .
[42] E. Schwarz, A. Parlesak, H.-H. Henneicke-von Zepelin, J. C. Bode, and C. Bode, “Effect of oral administration of freshly pressed juice of Echinacea purpurea on the number of various subpopulations of B- and T-lymphocytes in healthy volunteers: Results of a double-blind, placebo-controlled cross-over study,” Phytomedicine, vol. 12, no. 9, pp. 625–631, Sep. 2005, doi: 10.1016/j.phymed.2005.04.001 .
[43] “Life-SMS,” Life-SMS. Accessed: Dec. 22, 2023. [Online]. Available: https://lifesms.blog/
[43] “LifeStyle & MS,” LifeStyle & MS. Accessed: Dec.22, 2023. [Online]. Available: https://lsms.dsgip.de/
[45] “Zuzahlungen und Zuzahlungsfreistellungen für verschreibungspflichtige Arzneimittel.” Accessed: Dec. 18, 2023. [Online]. Available: https://www.bundesgesundheitsministerium.de/service/begriffe-von-a-z/z/zuzahlungsbefreiungen